Black Diamond Therapeutics, Inc.

US$1.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BDTXHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (36.49%)
Div yield —
ROE (37.21%)
Biotechnology
Beta (5Y) 3.46
PE TTM —
TSR TTM (55.17%)
Mkt cap US$99.68M
ROIC (20.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.16
24.47%
(81.46%)
Hold 12|1|8|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.04
10.83%
8.63%
19.38%
23.30%
Revenue$M
5.944
5.795
5.759
5.604
9.92%
1.61%
1.75%
(3.80%)
Peers (US$99.68M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.175
0.052
0.057
EBIT/Intx
2.237
1.087
1.051
Own earn%
(39.04)
171.56
141.30
Sh yield%
15.47
32.62
33.14
Owners
Insiders/Inst%
12.01
63.07
Short interest%
0.59
SBC / revenue%
3.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
18–26
$1 testx
0.3
Incr. ROIC%
6